Enhanced Recovery After Surgery in Hysterectomy Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorCairo University
About this trial
This prospective randomized controlled clinical trial aims to evaluate the effectiveness of Enhanced Recovery After Surgery (ERAS) protocols in patients undergoing elective hysterectomy. ERAS is an evidence-based perioperative approach designed to reduce surgical stress, accelerate recovery, and improve clinical outcomes. Participants will be randomized to receive either ERAS-based care or conventional perioperative management. The study will assess whether ERAS implementation reduces hospital stay and improves postoperative recovery without increasing complications.
Eligibility criteria
Qualifiers
Women aged 18-70 years.
Undergoing elective total hysterectomy for benign or early stage malignant gynacological conditions .
ASA ( American Society of Anesthesiologists ) physical status I-II.
Able to provide informed consent.
Disqualifiers
Emergency hysterectomy
Advanced malignant requiring extensive debulking
Known bowel disease or previous bowel surgery ( crohn's disease , bowel obstruction )
Significant cognitive impairment or psychiatric illness
Trial design
Treatments tested in this trial
- dextrose (5%)
- ERAS protocols
Treatment groups
78 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov